These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 1848011)

  • 1. Interaction of the v-rel protein with an NF-kappa B DNA binding site.
    Kabrun N; Hodgson JW; Doemer M; Mak G; Franza BR; Enrietto PJ
    Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1783-7. PubMed ID: 1848011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The v-rel oncogene: insights into the mechanism of transcriptional activation, repression, and transformation.
    Walker WH; Stein B; Ganchi PA; Hoffman JA; Kaufman PA; Ballard DW; Hannink M; Greene WC
    J Virol; 1992 Aug; 66(8):5018-29. PubMed ID: 1321284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The v-rel oncogene encodes a kappa B enhancer binding protein that inhibits NF-kappa B function.
    Ballard DW; Walker WH; Doerre S; Sista P; Molitor JA; Dixon EP; Peffer NJ; Hannink M; Greene WC
    Cell; 1990 Nov; 63(4):803-14. PubMed ID: 2225078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the DNA-binding and dimerization domains of v-Rel are responsible for altered kappa B DNA-binding complexes in transformed cells.
    Hrdlicková R; Nehyba J; Bose HR
    J Virol; 1995 Jun; 69(6):3369-80. PubMed ID: 7745683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.
    Ganchi PA; Sun SC; Greene WC; Ballard DW
    Mol Biol Cell; 1992 Dec; 3(12):1339-52. PubMed ID: 1493333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of v-rel in a replication competent virus: transformation and biochemical characterization.
    Morrison LE; Boehmelt G; Beug H; Enrietto PJ
    Oncogene; 1991 Sep; 6(9):1657-66. PubMed ID: 1656369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Avian I kappa B alpha is transcriptionally induced by c-Rel and v-Rel with different kinetics.
    Schatzle JD; Kralova J; Bose HR
    J Virol; 1995 Sep; 69(9):5383-90. PubMed ID: 7636983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Rel family: models for transcriptional regulation and oncogenic transformation.
    Bose HR
    Biochim Biophys Acta; 1992 Sep; 1114(1):1-17. PubMed ID: 1327144
    [No Abstract]   [Full Text] [Related]  

  • 9. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
    Carrasco D; Rizzo CA; Dorfman K; Bravo R
    EMBO J; 1996 Jul; 15(14):3640-50. PubMed ID: 8670867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the rel-homology domain alter the biochemical properties of v-rel and render it transformation defective in chicken embryo fibroblasts.
    Morrison LE; Boehmelt G; Enrietto PJ
    Oncogene; 1992 Jun; 7(6):1137-47. PubMed ID: 1594245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a C/EBP-Rel complex in avian lymphoid cells.
    Diehl JA; Hannink M
    Mol Cell Biol; 1994 Oct; 14(10):6635-46. PubMed ID: 7935382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic stimulation of avian I kappa B alpha transcription by rel and fos/jun factors.
    Kralova J; Schatzle JD; Liss AS; Bargmann W; Bose HR
    Oncogene; 1996 Jun; 12(12):2595-604. PubMed ID: 8700518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential pp40I kappa B-beta inhibition of DNA binding by rel proteins.
    Diehl JA; McKinsey TA; Hannink M
    Mol Cell Biol; 1993 Mar; 13(3):1769-78. PubMed ID: 8441412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive and inducible kappa B binding activities in the cytosol of v-Rel-transformed lymphoid cells.
    Hodgson J; Enrietto PJ
    J Virol; 1995 Mar; 69(3):1971-9. PubMed ID: 7853544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterologous C-terminal sequences disrupt transcriptional activation and oncogenesis by p59v-rel.
    Diehl JA; Hannink M
    J Virol; 1993 Dec; 67(12):7161-71. PubMed ID: 8230438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity.
    Inoue J; Kerr LD; Rashid D; Davis N; Bose HR; Verma IM
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4333-7. PubMed ID: 1533932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors.
    La Rosa FA; Pierce JW; Sonenshein GE
    Mol Cell Biol; 1994 Feb; 14(2):1039-44. PubMed ID: 8289784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The N-terminal env-derived amino acids of v-rel are required for full transforming activity.
    Garson K; Percival H; Kang CY
    Virology; 1990 Jul; 177(1):106-15. PubMed ID: 2162102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. I-Rel: a novel rel-related protein that inhibits NF-kappa B transcriptional activity.
    Ruben SM; Klement JF; Coleman TA; Maher M; Chen CH; Rosen CA
    Genes Dev; 1992 May; 6(5):745-60. PubMed ID: 1577270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The v-rel oncogene product is complexed with cellular proteins including its proto-oncogene product and heat shock protein 70.
    Lim MY; Davis N; Zhang JY; Bose HR
    Virology; 1990 Mar; 175(1):149-60. PubMed ID: 2155506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.